SVLSF IV, LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SVLSF IV, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SVLSF IV, LLC. SVLSF IV, LLC is 10% Owner in KalVista Pharmaceuticals, Inc. ($CBYL) and 10% Owner in ENTELLUS MEDICAL INC ($ENTL) and 10% Owner in OCULAR THERAPEUTIX, INC ($OCUL) and 10% Owner in NeurogesX Inc ($NGSX).
Latest Insider Trading Transactions of SVLSF IV, LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ENTL, KALV, NGSX, OCUL
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 10 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 29.40 | 374 | 10,994 | 47,471 | 47.8 K to 47.5 K (-0.78 %) |
Apr 10 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 29.40 | 13,157 | 386,753 | 1,672,105 | 1.7 M to 1.7 M (-0.78 %) |
Apr 10 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 28.53 | 377 | 10,756 | 47,845 | 48.2 K to 47.8 K (-0.78 %) |
Apr 10 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 28.53 | 13,292 | 379,227 | 1,685,262 | 1.7 M to 1.7 M (-0.78 %) |
Apr 10 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 29.49 | 629 | 18,550 | 48,222 | 48.9 K to 48.2 K (-1.29 %) |
Apr 10 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 29.49 | 22,171 | 653,865 | 1,698,554 | 1.7 M to 1.7 M (-1.29 %) |
Apr 02 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 28.76 | 253 | 7,277 | 48,851 | 49.1 K to 48.9 K (-0.52 %) |
Apr 02 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 28.76 | 8,888 | 255,653 | 1,720,725 | 1.7 M to 1.7 M (-0.51 %) |
Apr 02 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 27.66 | 1,458 | 40,326 | 49,104 | 50.6 K to 49.1 K (-2.88 %) |
Apr 02 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 27.66 | 51,373 | 1,420,885 | 1,729,613 | 1.8 M to 1.7 M (-2.88 %) |
Apr 02 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 28.40 | 969 | 27,516 | 50,562 | 51.5 K to 50.6 K (-1.88 %) |
Apr 02 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 28.40 | 34,133 | 969,241 | 1,780,986 | 1.8 M to 1.8 M (-1.88 %) |
Mar 28 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 27.80 | 1,012 | 28,135 | 51,531 | 52.5 K to 51.5 K (-1.93 %) |
Mar 28 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 27.80 | 35,653 | 991,189 | 1,815,119 | 1.9 M to 1.8 M (-1.93 %) |
Mar 28 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 29.06 | 1,599 | 46,466 | 52,543 | 54.1 K to 52.5 K (-2.95 %) |
Mar 28 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 29.06 | 56,318 | 1,636,556 | 1,850,772 | 1.9 M to 1.9 M (-2.95 %) |
Mar 28 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 29.70 | 831 | 24,679 | 54,142 | 55 K to 54.1 K (-1.51 %) |
Mar 28 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 29.70 | 29,262 | 869,008 | 1,907,090 | 1.9 M to 1.9 M (-1.51 %) |
Mar 20 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 26.70 | 7,246 | 193,468 | 54,973 | 62.2 K to 55 K (-11.65 %) |
Mar 20 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 26.70 | 255,224 | 6,814,481 | 1,936,352 | 2.2 M to 1.9 M (-11.65 %) |
Mar 06 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 23.04 | 893 | 20,572 | 62,219 | 63.1 K to 62.2 K (-1.41 %) |
Mar 06 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 23.04 | 31,439 | 724,245 | 2,191,576 | 2.2 M to 2.2 M (-1.41 %) |
Mar 06 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 22.91 | 1,197 | 27,420 | 63,112 | 64.3 K to 63.1 K (-1.86 %) |
Mar 06 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 22.91 | 42,181 | 966,240 | 2,223,015 | 2.3 M to 2.2 M (-1.86 %) |
Feb 21 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.60 | 4,764 | 98,138 | 64,309 | 69.1 K to 64.3 K (-6.90 %) |
Feb 21 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.60 | 167,779 | 3,456,247 | 2,265,196 | 2.4 M to 2.3 M (-6.90 %) |
Feb 21 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.02 | 641 | 12,830 | 69,073 | 69.7 K to 69.1 K (-0.92 %) |
Feb 21 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.02 | 22,594 | 452,239 | 2,432,975 | 2.5 M to 2.4 M (-0.92 %) |
Feb 21 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.73 | 508 | 10,532 | 69,714 | 70.2 K to 69.7 K (-0.72 %) |
Feb 21 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.73 | 17,912 | 371,366 | 2,455,569 | 2.5 M to 2.5 M (-0.72 %) |
Jan 07 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.41 | 72 | 1,470 | 70,222 | 70.3 K to 70.2 K (-0.10 %) |
Jan 07 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.41 | 2,527 | 51,581 | 2,473,481 | 2.5 M to 2.5 M (-0.10 %) |
Jan 07 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.01 | 47 | 941 | 70,294 | 70.3 K to 70.3 K (-0.07 %) |
Jan 07 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.01 | 1,653 | 33,081 | 2,476,008 | 2.5 M to 2.5 M (-0.07 %) |
Jan 02 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.00 | 6 | 120 | 70,341 | 70.3 K to 70.3 K (-0.01 %) |
Jan 02 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.00 | 194 | 3,880 | 2,477,661 | 2.5 M to 2.5 M (-0.01 %) |
Jan 02 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.00 | 702 | 14,043 | 70,347 | 71 K to 70.3 K (-0.99 %) |
Jan 02 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.00 | 24,716 | 494,419 | 2,477,855 | 2.5 M to 2.5 M (-0.99 %) |
Jan 02 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.03 | 103 | 2,063 | 71,049 | 71.2 K to 71 K (-0.14 %) |
Jan 02 2019 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.03 | 3,631 | 72,718 | 2,502,571 | 2.5 M to 2.5 M (-0.14 %) |
Dec 21 2018 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.02 | 59 | 1,181 | 71,152 | 71.2 K to 71.2 K (-0.08 %) |
Dec 21 2018 | KALV | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Sell | S | 20.02 | 2,077 | 41,577 | 2,506,202 | 2.5 M to 2.5 M (-0.08 %) |
Feb 02 2017 | ENTL | ENTELLUS MEDICAL I ... | SVLSF IV, LLC | 10% Owner | Sell | S | 17.00 | 8,501 | 144,517 | 50,849 | 59.4 K to 50.8 K (-14.32 %) |
Feb 02 2017 | ENTL | ENTELLUS MEDICAL I ... | SVLSF IV, LLC | 10% Owner | Sell | S | 17.00 | 299,424 | 5,090,208 | 1,791,070 | 2.1 M to 1.8 M (-14.32 %) |
Feb 02 2017 | ENTL | ENTELLUS MEDICAL I ... | SVLSF IV, LLC | 10% Owner | Sell | S | 17.00 | 2,106 | 35,802 | 10,424 | 12.5 K to 10.4 K (-16.81 %) |
Feb 02 2017 | ENTL | ENTELLUS MEDICAL I ... | SVLSF IV, LLC | 10% Owner | Sell | S | 17.00 | 2,615 | 44,455 | 12,947 | 15.6 K to 12.9 K (-16.80 %) |
Feb 02 2017 | ENTL | ENTELLUS MEDICAL I ... | SVLSF IV, LLC | 10% Owner | Sell | S | 17.00 | 220,431 | 3,747,327 | 1,091,166 | 1.3 M to 1.1 M (-16.81 %) |
Nov 25 2016 | CBYL | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Grant | A | 0.00 | 71,211 | 0 | 71,211 | 0 to 71.2 K |
Nov 25 2016 | CBYL | KalVista Pharmaceu ... | SVLSF IV, LLC | 10% Owner | Grant | A | 0.00 | 2,508,279 | 0 | 2,508,279 | 0 to 2.5 M |
Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Sell | S | 22.00 | 10,297 | 226,534 | 61,084 | 71.4 K to 61.1 K (-14.43 %) |
Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Sell | S | 22.00 | 362,703 | 7,979,466 | 2,151,523 | 2.5 M to 2.2 M (-14.43 %) |
Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Sell | S | 22.00 | 373,000 | 8,206,000 | 2,212,607 | 2.6 M to 2.2 M (-14.43 %) |
Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Sell | S | 22.00 | 373,000 | 8,206,000 | 2,212,607 | 2.6 M to 2.2 M (-14.43 %) |
May 05 2010 | NGSX | NeurogesX Inc | SVLSF IV, LLC | 10% Owner | Sell | S | 10.25 | 8,282 | 84,891 | 61,324 | 69.6 K to 61.3 K (-11.90 %) |
May 05 2010 | NGSX | NeurogesX Inc | SVLSF IV, LLC | 10% Owner | Sell | S | 10.25 | 291,718 | 2,990,110 | 2,159,991 | 2.5 M to 2.2 M (-11.90 %) |
Page: 1